| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$4,722,549,774 |
|
|
|
Indirect Value
|
$10,449,250 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$4,732,999,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
17
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
| Percentage
Gain/Loss : |
 51.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
officerTitle |
– – • |
2006-01-06 |
4 |
B |
$3.93 |
$58,950 |
I/I |
15,000 |
441,682 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
officerTitle |
– – • |
2006-01-06 |
4 |
B |
$3.93 |
$39,300 |
D/D |
10,000 |
2,019,000 |
2.37 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-05-22 |
4 |
B |
$3.95 |
$27,650 |
I/I |
7,000 |
478,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-05-18 |
4 |
B |
$4.00 |
$397,320 |
D/D |
99,330 |
2,168,330 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
officerTitle |
– – • |
2006-01-10 |
4 |
B |
$4.10 |
$335,980 |
I/I |
80,300 |
521,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-08-31 |
4 |
B |
$4.18 |
$216,001 |
D/D |
50,000 |
2,328,526 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-01 |
4 |
B |
$4.31 |
$90,006 |
D/D |
20,100 |
2,348,626 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-05 |
4 |
B |
$4.43 |
$163,713 |
D/D |
36,696 |
2,385,322 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-06 |
4 |
B |
$4.47 |
$18,166 |
D/D |
3,999 |
2,389,321 |
2.37 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-07 |
4 |
B |
$4.50 |
$86,774 |
D/D |
19,036 |
2,408,357 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-18 |
4 |
B |
$4.75 |
$84,275 |
D/D |
17,742 |
2,430,211 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-19 |
4 |
B |
$4.75 |
$91,540 |
D/D |
19,216 |
2,449,427 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-11-08 |
4 |
B |
$4.75 |
$71,250 |
I/I |
15,000 |
446,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-11-08 |
4 |
B |
$4.75 |
$1,854,000 |
D/D |
390,000 |
2,862,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-08 |
4 |
B |
$4.80 |
$19,738 |
D/D |
4,112 |
2,412,469 |
2.37 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-12-29 |
4 |
B |
$4.85 |
$155,560 |
D/D |
31,661 |
2,894,617 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-01-03 |
4 |
B |
$4.85 |
$529,276 |
D/D |
108,339 |
3,002,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-09-20 |
4 |
B |
$4.88 |
$115,208 |
D/D |
23,529 |
2,472,956 |
2.45 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • • |
2021-05-12 |
4 |
B |
$5.24 |
$59,557,426 |
D/D |
11,365,921 |
67,662,454 |
3.23 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,231,624 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-08-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,233,291 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-07 |
4 |
OE |
$5.95 |
$78,927 |
D/D |
13,265 |
36,246,556 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,392,861 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-06 |
4 |
OE |
$5.95 |
$59,101 |
D/D |
9,933 |
36,601,741 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-17 |
4 |
B |
$6.09 |
$123,470 |
D/D |
20,241 |
36,266,797 |
3.92 |
% |
|
318 Records found
|
|
Page 6 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
